Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunity to intracellular bacteria.
Kaufmann SH, Follows GA, Munk ME. Kaufmann SH, et al. Among authors: follows ga. Mem Inst Oswaldo Cruz. 1992;87 Suppl 5:91-4. doi: 10.1590/s0074-02761992000900013. Mem Inst Oswaldo Cruz. 1992. PMID: 1342723 Free article. Review.
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper.
Barrett A, Shah N, Chadwick A, Burns D, Burton C, Cutter DJ, Follows GA, McKay P, Osborne W, Phillips E, Wilson MR, Collins GP. Barrett A, et al. Among authors: follows ga. Br J Haematol. 2024 Nov 6. doi: 10.1111/bjh.19840. Online ahead of print. Br J Haematol. 2024. PMID: 39506502
Transverse Leukonychia (Mees' Lines).
Follows AM, Follows GA. Follows AM, et al. Among authors: follows ga. N Engl J Med. 2023 Nov 30;389(22):e48. doi: 10.1056/NEJMicm2304533. Epub 2023 Nov 25. N Engl J Med. 2023. PMID: 38009615 No abstract available.
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Niemann CU, Munir T, Moreno C, Owen C, Follows GA, Benjamini O, Janssens A, Levin MD, Robak T, Simkovic M, Voloshin S, Vorobyev V, Yagci M, Ysebaert L, Qi K, Qi Q, Sinet P, Parisi L, Srinivasan S, Schuier N, Baeten K, Howes A, Caces DB, Kater AP. Niemann CU, et al. Among authors: follows ga. Lancet Oncol. 2023 Dec;24(12):1423-1433. doi: 10.1016/S1470-2045(23)00452-7. Epub 2023 Nov 6. Lancet Oncol. 2023. PMID: 37944541 Clinical Trial.
66 results